Cargando…
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Herein we show that a majority of human brain tumor samples and cell lines over-expressed cannabinoid receptor CB1 as compared to normal human astrocytes (NHA), while uniformly expressed low levels of CB2. This finding prompted us to investigate the therapeutic exploitation of CB1 inactivation by SR...
Autores principales: | Ciaglia, Elena, Torelli, Giovanni, Pisanti, Simona, Picardi, Paola, D'Alessandro, Alba, Laezza, Chiara, Malfitano, Anna Maria, Fiore, Donatella, Zottola, Antonio Christian Pagano, Proto, Maria Chiara, Catapano, Giuseppe, Gazzerro, Patrizia, Bifulco, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558164/ https://www.ncbi.nlm.nih.gov/pubmed/26008966 |
Ejemplares similares
-
p53 regulates the mevalonate pathway in human glioblastoma multiforme
por: Laezza, C, et al.
Publicado: (2015) -
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma
por: Abate, Mario, et al.
Publicado: (2017) -
Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2008) -
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2013) -
Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation
por: Murumalla, Ravi, et al.
Publicado: (2011)